I am hoping TDCP management will issue an Executive Summary or a Letter to the Shareholders providing an outline or the highlights of the October 15th meeting. I had several questions about the r/s. So far from the comments I have read here on the board, I cannot find that my questions have been answered by TDCP--the questions I submitted before the October 15 meeting. For example, will they forgo the r/s if the stock price for whatever reason goes to .50 to a $1.00? [This question is more relevant now than ever. Now that TDCP has publically established an outside date (12 months) for the proto-type, TDCP stock price can appreciate solely on speculation alone. In February 2009, I bought CTIC stock for .081. I sold those shares in February 2010 for $1.01. CTIC is a bio stock and she was coming up for a FDA hearing in 2010. She lost approval of her drug but the stock went up on speculation alone. True, TDCP is not a bio stock but the speculative factor will kick in now and grow as the 12 months proceed. I must confess I was wrong about how far along TDCP was in making the proto type. I believed they had it (and might announce it during the Oct. meeting) or were much further along than they are now indicating.] Some of my other questions are: How soon after the r/s will they issue the new shares to those of us who hold our shares through the r/s? What criteria will management use to decide in favor of a r/s of 15:1 verses 35:1? Will it be solely TDCP’s stock price? Maybe somebody who attended the meeting will answer my questions on Monday. Finally, from what I can tell from the comments posted so far from those who attended the meeting, I am convinced more than ever that TDCP will pay off big time. Apparently, there is a little surprise coming to us that management for legal/security reasons will not share with us at this time. I like surprises!! The one thing I fear more than anything is a buy out. Big money people must know where the future is. They know its 3D. However, I think we may have some protection from a buy out. The CSpace patent is owned by OKU. TDCP has a SRA to use the CSpace patent. There may be clause in the SRA that states that the SRA is non-transferable.I wish I could read what the SRA says. I do not want a buyout. I prefer to keep as much of the future profits in my checking account as possible. lol.
